# Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD).

> **NCT02602483** · PHASE1,PHASE2 · COMPLETED · sponsor: **Spherium Biomed** · enrollment: 96 (actual)

## Conditions studied

- Temporomandibular Joint Disorders

## Interventions

- **DRUG:** Ibuprofen
- **DRUG:** Magnesium
- **DRUG:** Ascorbic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02602483
- **Lead sponsor:** Spherium Biomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2017-01-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02602483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02602483, "Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD).". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02602483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*